Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)

NCT04172753 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04172753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04172753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Recruiting
Start date
May 9, 2018
Completion date
May 9, 2027
Enrollment
472 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, esophageal cancer, head and neck cancer, liver cancer, oligometastasis, prostate cancer, rectal cancer